The Effect of Interferon-γ on Bleomycin Induced Pulmonary Fibrosis in the Rat |
Yoon, Hyoung Kyu
(Division of Pulmonology, Department of Internal Medicine, College of Medicine, the Catholic University of Korea)
Kim, Yong Hyun (Division of Pulmonology, Department of Internal Medicine, College of Medicine, the Catholic University of Korea) Kwon, Soon Seog (Division of Pulmonology, Department of Internal Medicine, College of Medicine, the Catholic University of Korea) Kim, Young Kyoon (Division of Pulmonology, Department of Internal Medicine, College of Medicine, the Catholic University of Korea) Kim, Kwan Hyung (Division of Pulmonology, Department of Internal Medicine, College of Medicine, the Catholic University of Korea) Moon, Hwa Sik (Division of Pulmonology, Department of Internal Medicine, College of Medicine, the Catholic University of Korea) Park, Sung Hak (Division of Pulmonology, Department of Internal Medicine, College of Medicine, the Catholic University of Korea) Song, Jeong Sup (Division of Pulmonology, Department of Internal Medicine, College of Medicine, the Catholic University of Korea) |
1 | Cottin V, Cordier JF. [Idiopathic diffuse interstitial lung disease]. Rev Prat 2000;50:1901-5 |
2 | Selman M, Carrillo G, Salas J, et al. Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial. Chest 1998;114:507-12 |
3 | Snider GL, Hayes JA, Korthy AL. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin: pathology and stereology. Am Rev Respir Dis 1978; 117:1099-108 |
4 | Khalil N, Greenberg AH. The role of TGF-beta in pulmonary fibrosis. Ciba FoundSymp 1991; 157:194-207; discussion 207-11 |
5 | Chensue SW, Otterness IG, Higashi GI, Forsch CS, Kunkel SL. Monokine production by hypersensitivity (Schistosoma mansoni egg) and foreign body (Sephadex bead)-type granuloma macrophages. Evidence for sequential production of IL-1 and tumor necrosis factor. J Immunol 1989; 142:1281-6 |
6 | Clark IM, Powell LK, Cawston TE. Tissue inhibitor of metalloproteinases(TIMP-1) stimulates the secretion of collagenase from human skin fibroblasts. Biochem Biophys Res Commun 1994; 203:874-80 |
7 | Baecher-Allan CM, Barth RK. PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis. Reg Immunol 1993;5:207-17 |
8 | Woessner JF, Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961; 93:440-7 |
9 | Guedez L, Stetler-Stevenson WG, Wolff L, et al. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 1998;102:2002-10. |
10 | Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler 1995; 376:345-55 |
11 | Underwood DC, Osborn RR, Bochnowicz S, et al. SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am J Physiol Lung Cell Mol Physiol 2000; 279:L895-902 |
12 | Izbicki G, Segel MJ, Christensen TG, Conner MW, Breuer R. Time course of bleomycininduced lung fibrosis. Int J Exp Pathol 2002;83:111-9 |
13 | Jaffe HA, Gao Z, Mori Y, Li L, Varga J. Selective inhibition of collagen gene expression in fibroblasts by an interferon-gamma transgene. Exp Lung Res 1999;25:199-215 |
14 | Betsuyaku T, Fukuda Y, Parks WC, Shipley JM, Senior RM. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am J Pathol 2000;157:525-35 |
15 | Lukacs NW, Hogaboam C, Chensue SW, Blease K, Kunkel SL. Type 1/type 2 cytokine paradigm and the progression of pulmonary fibrosis. Chest 2001; 120:5S-8S |
16 | Corbel M, Caulet-Maugendre S, Germain N, Molet S, Lagente V, Boichot E. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. J Pathol 2001;193:538-45 |
17 | Lemjabbar H, Gosset P, Lechapt-Zalcman E, et al. Overexpression of alveolar macrophage gelatinase B(MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment. Am J Respir Cell Mol Biol 1999; 20:903-13 |
18 | Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH. A preliminary study oflong-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999; 341:1264-9 |
19 | Shapiro SD. Diverse roles of macrophage matrix metalloproteinases in tissue destruction and tumor growth. Thromb Haemost 1999; 82:846-9. |
20 | Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 2003; 28:12-24 |
21 | Woessner JF, Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. Faseb J 1991; 5:2145-54 |
22 | Schwartz DA, Helmers RA, Galvin JR, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994;149:450-4. |
23 | Selman M, Ruiz V, Cabrera S, et al. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment Am J Physiol Lung Cell Mol Physiol 2000; 279:L562-74 |
24 | Bachwich PR, Lynch JP, 3rd, Larrick J, Spengler M, Kunkel SL. Tumor necrosisfactor production by human sarcoid alveolar macrophages. Am J Pathol 1986; 125:421-5 |
25 | Madtes DK, Elston AL, Kaback LA, Clark JG. Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2001; 24:599-607 |
26 | Huaux F, Liu T, McGarry B, Ullenbruch M, Phan SH. Dual roles of IL-4 in lung injury and fibrosis. J Immunol 2003; 170:2083-92 |
27 | Parks WC, Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res 2001;2:10-9 |
28 | Perez-Ramos J, de Lourdes Segura-Valdez M, Vanda B, Selman M, Pardo A. Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis. Am J Respir Crit Care Med 1999; 160:1274-82 |
29 | Durum SK, Schmidt JA, Oppenheim JJ. Interleukin 1: an immunological perspective. Annu Rev Immunol 1985; 3:263-87 |
30 | Hyde DM, Henderson TS, Giri SN, Tyler NK, Stovall MY. Effect of murine gammainterferon on the cellular responses to bleomycin in mice. Exp Lung Res 1988;14:687-704 |
31 | Chen ES, Greenlee BM, Wills-Karp M, Moller DR. Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin. Am J Respir Cell Mol Biol 2001; 24:545-55 |
32 | Boraschi D, Censini S, Tagliabue A. Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production. J Immunol 1984; 133:764-8 |
33 | Suga M, Iyonaga K, Okamoto T, et al. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2000; 162:1949-56. |
34 | Raghu G, Depaso WJ, Cain K, et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebocontrolled clinical trial. Am Rev Respir Dis 1991; 144:291-6 |
35 | Brown PD, Kleiner DE, Unsworth EJ, Stetler-Stevenson WG. Cellular activation ofthe 72 kDa type IV procollagenase/TIMP-2 complex. Kidney Int 1993; 43:163-70 |